293 results
8-K
EX-5.1
BMY
Bristol-Myers Squibb Co.
22 Feb 24
Other Events
4:15pm
having made any special investigation as to the applicability of another statute, law, rule or regulation. None of the opinions or other advice contained
8-K
EX-1.1
BMY
Bristol-Myers Squibb Co.
22 Feb 24
Other Events
4:15pm
of any claim under any environmental laws and the Company is not aware of any pending investigation that could reasonably be expected to lead … by such indemnified party, in connection with the defense thereof other than reasonable costs of investigation. Notwithstanding the foregoing
424B5
BMY
Bristol-Myers Squibb Co.
16 Feb 24
Prospectus supplement for primary offering
4:34pm
on our experience in the industry and our own investigation of market conditions. We believe these estimates to be accurate as of the date
424B2
10uoks1n6n996b5tgg3
13 Feb 24
Prospectus for primary offering
8:00am
SC TO-T
EX-99
qo0omujbitvjhkojxu
25 Jan 24
Third party tender offer statement
8:13am
SC TO-T
EX-99
b1xxlkn8 t09xr5aio
25 Jan 24
Third party tender offer statement
8:13am
8-K
EX-5.1
zteu7
13 Nov 23
Other Events
4:19pm
8-K
EX-1.1
y4q7rz
13 Nov 23
Other Events
4:19pm
424B5
qm3i 4mm72av
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
4sqtcl3e5 6mzcni0l
30 Oct 23
Prospectus supplement
8:05am
DEFA14A
37hl58s
10 Apr 23
Additional proxy soliciting materials
5:12pm